Follow and listen to our podcast

StashLearn
Get the app
Get the app

Join millions of investors on Stash

Investing, simplified

Start today with as little as $5
Get the app
Stash
Investment Profile

Corporate Cannabis: Investing in Marijuana on Stash

Holdings

Cronos Group, Aurora Cannabis, Canopy Growth, and more

Managed by

ETF Management Group
Ticker: MJ

Risk Level

Aggressive

Risk Level

Aggressive

Grass, pot, Mary Jane, weed–marijuana has a lot of slangy names that point to its controversial history.

But attitudes toward marijuana, whose scientific name is cannabis, are changing quickly, and its recreational use is becoming more acceptable. Nearly two thirds of Americans say use of marijuana should be legal, according to a 2017 Gallup poll. That’s up from 60% in 2016, and just 34% in 2002.

Nearly two thirds of Americans say use of marijuana should be legal, according to a 2017 Gallup poll.

Corporate Cannabis is hoping to capture the industry growth. Corporate Cannabis, which is the Stash nickname for  ETFMG Alternative Harvest ETF (Ticker: MJ), an exchange-traded fund (ETF) that offers investors exposure to companies that are leading the way in the burgeoning marijuana industry.

Marijuana and the law

While U.S. federal law still considers marijuana  use and possession illegal, eight states and the District of Columbia have in recent years legalized cannabis for recreational use. And in January, California became the largest state in the U.S. to allow its residents to use marijuana  for pleasure, with a market of nearly $4 billion in 2018, according to reports.

There are now 29 states that allow doctors to prescribe cannabis for medical purposes, which can include helping to alleviate nausea related to chemotherapy, and stimulation of appetite for people who are chronically ill, among other things. (On the international front, Canada may soon be the first developed nation to make recreational and medicinal marijuana use fully legal.)

Source: Third Way

And it all makes for big business. Total legal sales of cannabis in the U.S. were about $8 billion in 2017, and are expected to grow to $24.5 billion by 2021, according to the research group New Frontier.

Can I get in trouble with the law if I invest in Corporate Cannabis on Stash?

The short answer is no. While the government can file charges against a company, simply owning securities generally doesn’t put you in any real legal danger. If there any further questions on the legality of this specific investment, we encourage you to read through the fund’s prospectus.

What’s in the fund?

Corporate Cannabis tracks the Prime Alternative Harvest Index, which includes the stock of 30 public companies internationally that are “engaged in the legal cultivation of cannabis, or the legal production, marketing or distribution of cannabis products for medical or non-medical purposes,” according to the fund prospectus.

Although the majority of the companies in the fund are based in North America, according to Morningstar, the fund does not include any companies that grow or distribute marijuana in the U.S., due to the federal prohibition on cannabis. When the fund invests in cannabis businesses, the companies are located primarily in Canada, and derive at least 50% of their revenue from legal cultivation or production of cannabis, according to the prospectus.

The 30 companies in the fund include Cronos Group and Cannimed, both medical marijuana companies based in Canada, as well as the pharmaceutical firms Arena Pharmaceuticals and GW Pharmaceuticals.

Source: ETF. com

Corporate Cannabis also includes more traditional tobacco companies that aren’t currently actively involved in the cannabis space, but may one day stake a claim in legal marijuana, according to reports.

Those include U.S.-based tobacco companies Altria and Philip Morris, as well as Denmark’s Scandinavian Tobacco group, and China’s Huabao, among others.

Corporate Cannabis: Fund performance and other details

The fund, which is managed by ETF Managers Group, officially launched on December 26, 2017.

MJ was previously structured as a real estate fund called Tierra XP Latin America Real Estate ETF, according to the prospectus. Sam Masucci, the founder and chief executive officer of ETF Managers Group said in a press release at the time the fund launched, that MJ is about giving “investors exposure to new markets and doing our part to impact the continued evolution of the ETF industry by meeting the appetite of investor interest.”

Year to date, the share price of the fund has increased 16.36%, as of January 9, 2018, according to Morningstar.

By comparison, a similar fund, known as Vicex, which invests in so-called vice stocks including those of tobacco, beer, and gambling companies, had a year to date increase of 0.28% as of January 9, 2018, according to Morningstar.  

Investing, simplified.

Start investing in funds like this on Stash.

Get the App

Corporate Cannabis (MJ) has a management fee of 0.75%, according to the fund prospectus. While that’s relatively low compared to some funds, it’s also higher than the average expense ratio for an ETF, which  is 0.43%, according to ETFdb.com. Fees can reduce investment returns.

Risks and considerations

The companies held by the fund may be subject to heightened legal risk, as use and possession of marijuana is currently illegal under U.S. federal law, and under many state laws and international laws.

As such, cannabis companies and companies involved in selling cannabis products may have limited access to banks, and may never be allowed to sell their products entirely legally in the U.S., and in other countries where cannabis is also illegal, according to Morningstar and the fund’s prospectus. Companies that produce tobacco also face heightened regulatory controls.

Corporate Cannabis is considered a risky investment. Stash will send you an overexposure warning, urging you to diversify, if you invest more than $100 in Corporate Cannabis, and that amount represents more than 10% of your portfolio.

Top Takeaways

Investing, simplified

Start today with as little as $5

Get the App

*Stash does not endorse the illegal use of Narcotics.

By Stash Team

Next for you
Up & Coming: Why Invest In An Emerging Markets ETF?
Explore more articlesChoose a topic to learn more about
money lessons Retirement politics love and money social media

Start investing

Start now with as little as $5.
Get the App
Disclaimers

This material has been distributed for informational and educational purposes only, represents an assessment of the market environment as of the date of publication, is subject to change without notice, and is not intended as investment, legal, accounting, or tax advice or opinion. Stash assumes no obligation to provide notifications of changes in any factors that could affect the information provided. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. The strategies discussed are strictly for illustrative and educational purposes and should not be construed as a recommendation to purchase or sell, or an offer to sell or a solicitation of an offer to buy any security. There is no guarantee that any strategies discussed will be effective.

Furthermore, the information presented does not take into consideration commissions, tax implications, or other transactional costs, which may significantly affect the economic consequences of a given strategy or investment decision. This information is not intended as a recommendation to invest in any particular asset class or strategy or as a promise of future performance. There is no guarantee that any investment strategy will work under all market conditions or is suitable for all investors. Each investor should evaluate their ability to invest long term, especially during periods of downturn in the market. Investors should not substitute these materials for professional services, and should seek advice from an independent advisor before acting on any information presented. Before investing, please carefully consider your willingness to take on risk and your financial ability to afford investment losses when deciding how much individual security exposure to have in your investment portfolio.

Past performance does not guarantee future results. There is a potential for loss as well as gain in investing. Stash does not represent in any manner that the circumstances described herein will result in any particular outcome. While the data and analysis Stash uses from third party sources is believed to be reliable, Stash does not guarantee the accuracy of such information. Nothing in this article should be considered as a solicitation or offer, or recommendation, to buy or sell any particular security or investment product or to engage in any investment strategy. No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission. Stash does not provide personalized financial planning to investors, such as estate, tax, or retirement planning. Investment advisory services are only provided to investors who become Stash Clients pursuant to a written Advisory Agreement. For more information please visit www.stashinvest.com/disclosures.

Marijuana is still considered an illegal substance under federal law. Stash does not condone or encourage the use of marijuana or any other illegal substance. Investing in marijuana related investment products is considered high risk and should be done with caution as part of a well diversified portfolio.